AstraZeneca Pharmaceuticals agreed to pay $425 million to settle lawsuits from about 11,000 consumers alleging they suffered kidney injuries after taking Nexium and Prilosec.
The settlement, announced on Tuesday, is the largest so far in the multidistrict litigation involving proton-pump inhibitor medications, used to treat heartburn and stomach acid. Three other companies—GlaxoSmithKline, Procter & Gamble and Pfizer—reached prior settlements totaling $108.5 million.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
